← Back to Patent Explorer
US4026897A Expired / Lapsed US ⏱️ 0.0 years remaining

5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxycarbostyril derivatives

Assignee: Otsuka Pharmaceutical Co Ltd
•
Filing: 1974-12-26
•
Granted: 1977-05-31
•
Expires: 1994-12-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 5-[1-Hydroxy-2-(substituted-amino)]alkyl -8-hydroxy-carbostyril derivatives represented by the formula (I) ##STR1## wherein R 1 represents an alkyl group having 1 to 4 carbon atoms and R 2 and R 3 , which may be the same or different, each represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an aralkyl group containing a straight or branched chain alkyl moiety having 1 to 4 carbon atoms or a cycloalkyl group having 4 to 6 carbon atoms, or R 2 and R 3 may, when taken together with the nitrogen atom to which they are attached, form a 5- or 6-membered substituted or unsubstituted heterocyclic ring containing 1 or 2 nitrogen, oxygen or sulfur atoms as hetero atoms, the pharmaceutically acceptable acid addition salts thereof, and a process for preparing the same.

Inventors

  • 👤 Kazuyuki Nakagawa
  • 👤 Shiro Yoshizaki
  • 👤 Kaoru Tanimura
  • 👤 Shigeharu Tamada

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 20:32
CPC Classifications
C; C07; C07C; C07C255/00; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/47; C07D; C07D215/00; C07D215/02; C07D215/16; C07D215/20; C07D215/22; C07D215/24; C07D215/26; C07D215/32

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 134 words
A 5-[1-hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-carbostyril compound represented by the formula (I) ##STR16## wherein R 1 represents an alkyl group having 1 to 4 carbon atoms and R 2 and R 3 , which may be the same or different, each represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, a phenylalkyl group having a straight or branched chain alkyl moiety having 1 to 4 carbon atoms or a cycloalkyl group having 4 to 6 carbon atoms, or R 2 and R 3 may, when taken together with the nitrogen atom to which they are attached, form a 5- or 6- membered heterocyclic ring, substituted by an alkyl group having 1-4 carbon atoms or unsubstituted selected from the group consisting of pyrrolidino, piperidino, morpholino and piperazino and the pharmaceutically acceptable acid addition salts thereof.
Claim 2
Dependent Claim 134 words
A 5-[1-hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-carbostyril compound represented by the formula (I) ##STR16## wherein R 1 represents an alkyl group having 1 to 4 carbon atoms and R 2 and R 3 , which may be the same or different, each represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, a phenylalkyl group having a straight or branched chain alkyl moiety having 1 to 4 carbon atoms or a cycloalkyl group having 4 to 6 carbon atoms, or R 2 and R 3 may, when taken together with the nitrogen atom to which they are attached, form a 5- or 6- membered heterocyclic ring, substituted by an alkyl group having 1-4 carbon atoms or unsubstituted selected from the group consisting of pyrrolidino, piperidino, morpholino and piperazino and the pharmaceutically acceptable acid addition salts thereof.
Claim 3
Dependent Claim 134 words
A 5-[1-hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-carbostyril compound represented by the formula (I) ##STR17## wherein R 1 represents an alkyl group having 1 to 4 carbon atoms and R 2 and R 3 , which may be the same or different, each represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, a phenylalkyl group having a straight or branched chain alkyl moiety having 1 to 4 carbon atoms or a cycloalkyl group having 4 to 6 carbon atoms, or R 2 and R 3 may, when taken together with the nitrogen atom to which they are attached, form a heterocyclic ring which is unsubstituted or substituted by an alkyl group having 1-4 carbon atoms, said heterocyclic ring being selected from the group consisting of piperidino and pyrrolidino, and the pharmaceutically acceptable acid addition salts thereof.
Claim 4
Dependent Claim 134 words
A 5-[1-hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-carbostyril compound represented by the formula (I) ##STR17## wherein R 1 represents an alkyl group having 1 to 4 carbon atoms and R 2 and R 3 , which may be the same or different, each represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, a phenylalkyl group having a straight or branched chain alkyl moiety having 1 to 4 carbon atoms or a cycloalkyl group having 4 to 6 carbon atoms, or R 2 and R 3 may, when taken together with the nitrogen atom to which they are attached, form a heterocyclic ring which is unsubstituted or substituted by an alkyl group having 1-4 carbon atoms, said heterocyclic ring being selected from the group consisting of piperidino and pyrrolidino, and the pharmaceutically acceptable acid addition salts thereof.
Claim 5
Dependent Claim 5 words
5-(1-Hydroxy-2-isopropylamino)butyl-8-hydroxycarbostyril according to claim 2.
Claim 6
Dependent Claim 5 words
5-(1-Hydroxy-2-sec-butylamino)butyl-8-hydroxycarbostyril according to claim 2.
Claim 7
Dependent Claim 5 words
5-(1-Hydroxy-2-ethylamino)butyl-8-hydroxycarbostyril according to claim 2.
Claim 8
Dependent Claim 5 words
5-[1-Hydroxy-2-(2-phenethylamino)]butyl-8-hydroxycarbostyril according to claim 2.
Claim 9
Dependent Claim 5 words
5-(1-Hydroxy-2-isopropylamino)propyl-8-hydroxycarbostyril according to claim 2.
Claim 10
Dependent Claim 5 words
5-(1-Hydroxy-2-tert-butylamino)propyl-8-hydroxycarbostyril according to claim 2.

References Cited (Backward Citations)

US3555030A Cited
US3444173A Cited
DE2261506A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-05-30 1980-11-29 1981-05-31 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-05-30 1984-11-29 1985-05-31 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-05-30 1988-11-29 1989-05-31 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag